FDA grants priority review for AbbVie... - HFI Connect - Hep...

HFI Connect - Hepatitis

959 members1,215 posts

FDA grants priority review for AbbVie's pan-genotypic HCV regimen

HFIAdmin profile image
0 Replies

It has been weeks since AbbVie's New #Drug Application for glecaprevir/pibrentasvir. At last, the #FDA replied and approved the new regimen. Click below for a recap of the application. #health #HCV #hepatitis

bit.ly/2lczWF9

Written by
HFIAdmin profile image
HFIAdmin
To view profiles and participate in discussions please or .